Guidance and quality standards awaiting development | Guidance

Showing 21 to 30 of 381

Guidance and quality standards awaiting development
Title	Type
Artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning: early value assessment	HealthTech guidance
Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care	HealthTech guidance
Artificial intelligence (AI)-derived software to help clinical decision making in stroke	HealthTech guidance
Asciminib for untreated Philadelphia-chromosome-positive chronic myeloid leukaemia in the chronic phase	Technology appraisal guidance
Asundexian for preventing stroke after acute non-cardioembolic ischaemic stroke or high-risk transient ischaemic attack [GID-TA12033]	Technology appraisal guidance
Atrasentan for treating primary IgA nephropathy [ID6558]	Technology appraisal guidance
Avexitide for treating hypoglycaemia after bariatric surgery [ID6725]	Technology appraisal guidance
Baloxavir marboxil for treating influenza in people 12 years and over at high risk of complications [ID3794]	Technology appraisal guidance
Baloxavir marboxil granules for treating and preventing influenza in people 3 weeks and over [TSID12432]	Technology appraisal guidance
Belzutifan for treating advanced pheochromocytoma or paraganglioma [ID6719]	Technology appraisal guidance